Spine-health.com's online poll shows that back pain sufferers use Advil, Aleve most.
Half of back pain sufferers reach for Advil or Aleve for relief, according to an online poll conducted by
FDA Approves Second Formulation of Humira Biosimilar Cyltezo
May 1st 2024According to Michael Osso, president and chief executive officer of the Crohn’s & Colitis Foundation, “the flexibility of having multiple biosimilar formulations to choose from is important to support broader patient access to biologic medicine.”